Antineoplastic drug-associated adverse cardiovascular events (ACEs) are a concern; however, information on new antineoplastic drugs is limited. In this situation, signal detection and hypothesis build
Studies of adverse drug events (ADEs) are important in order not to jeopardize the positive impact of pharmacotherapy. These events have substantial impact on the population morbidity profiles, and in
Characteristics of adverse drug reaction cases to cefaclor and other 2nd and 3rd cephalosporins in the Korean Adverse Event Reporting System database for the most recent 5 years.
